iStock Rating

D
Details...
Enter Symbol click to research

Advisory Board Company (The) (NASDAQ: ABCO)

Sector: Medical

Current Price : $47.07

52 Week Low
$41.08
52 Week High
$55.00
 

ADVISORY B(NSDQ:ABCO)
The Advisory Board Company provides best practices research and analysis to the health care industry, focusing on business strategy, operations and general management issues. The Company provides its best practices research and analysis through discrete annual programs to a membership of more than 2,000 hospitals, health systems, pharmaceutical and biotech companies, health care insurers, and medical device companies in the United States. Each program provides members with best practices research reports, executive education and other supporting research services.
# Employees: 1850
Address: 2445 M STREET NW,WASHINGTON,DC,USA
Phone: 202-266-5600
Fax: 202-266-5700
Website: www.advisory.com
Email: jacobsg@advisory.com
Sector: Medical
Industry: Medical Services
Executive Officers
Frank J. Williams (Chairman)
Robert W. Musslewhite (C.E.O. and Director)
Michael T. Kirshbaum (C.F.O. and Treasurer)
Sanju K. Bansal (Director)
Peter J. Grua (Director,)
Dividend
Ex-Dividend Date: N/A
Annual Dividend: N/A
Current Dividend Yield: N/A
Dividend Paid (3 months): N/A
Indicated Dividend: N/A
Earnings
Last Earnings Date: 12/31/2012
Next Earnings Date(Expected): 5/9/2013
Mean EPS (Next Qtr): $0.24
Mean EPS (Year): $1.03
Mean Estimate(Long Term): $19.00
P/E Ratio(Based on EPS estimate): 45.690
Number of Estimates: 3
Shares Performance
Period abco Compare to S&P
YTD 0.58 % -7.77 %
4 Weeks -8.01 % -7.92 %
12 Weeks -12.66 % -15.59 %
Shares Information
Analyst Coverage: Y
Avg Volume: 184094
Shares Outstanding: 35M
Market Cap: $1.65B
52 Week High: $55.00
52 Week Low: $41.08
P/E Ratio: 38.570
PEG Ratio: 2.400
Split: On 6/19/2012 abco split by factor of 2.000
Earnings Performance
EPS Growth in Last Quarter: -12.00 %
EPS Growth in Last Year: -6.38 %
Sales Growth in Last Quarter: 4.94 %
Sales Growth in Last Quarter: 16.18 %
Financials
Qtr Book Value: $6.16
Cash Flow/Share: $32.73
Change in Payout Ratio: -0.010
Price/Sales: -0.010
Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia. Advertisement partners Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.